Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Heska Fourth Quarter and Full Year 2021 Financial Results and Earnings Call


PR Newswire | Jan 31, 2022 08:01AM EST

Scheduled for February 28, 2022

01/31 07:00 CST

Heska Fourth Quarter and Full Year 2021 Financial Results and Earnings Call Scheduled for February 28, 2022 LOVELAND, Colo., Jan. 31, 2022

LOVELAND, Colo., Jan. 31, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products and solutions, will report its fourth quarter and full year 2021 financial performance in a press release before the market opens on Monday, February 28, 2022. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results.

To access the conference call:From within the United States, please dial 1-800-239-9838From outside of the United States, please dial 1-323-794-2551Reference Conference ID: 3732352

The earnings call will be webcast live from the Company's investor relations website at Heska Fourth Quarter and Full Year 2021 Earnings Call Webcast.

A telephonic replay will be available at 2 p.m. ET on February 28 through 11:59 p.m. ET on March 14, 2022 and the webcast will be archived on the Company's website for 90 days.

To access the replay:From within the United States, please dial 1-844-512-2921From outside the United States, please dial 1-412-317-6671Reference Replay Pin Number: 3732352

About HeskaHeska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health. For more information, please visit www.heska.com.

View original content to download multimedia: https://www.prnewswire.com/news-releases/heska-fourth-quarter-and-full-year-2021-financial-results-and-earnings-call-scheduled-for-february-28-2022-301471094.html

SOURCE Heska Corporation






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC